Ling Xu

机构：Shanghai Jiao Tong University, XinHua Hospital, Tongren Hospital, Shanghai Sixth People's Hospital · ORCID：0000-0002-3438-8432

发表论文 107 篇 · 总被引 3836 次 · h-index 36

代表论文

• OGDHL silencing promotes hepatocellular carcinoma by reprogramming glutamine metabolism (2019 · Journal of Hepatology · 被引 192)
• CD151-enriched migrasomes mediate hepatocellular carcinoma invasion by conditioning cancer cells and promoting angiogenesis (2024 · Journal of Experimental & Clinical Cancer Research · 被引 74)
• APCCDC20-mediated degradation of PHD3 stabilizes HIF-1a and promotes tumorigenesis in hepatocellular carcinoma (2020 · Cancer Letters · 被引 70)
• Bergenin Exerts Hepatoprotective Effects by Inhibiting the Release of Inflammatory Factors, Apoptosis and Autophagy via the PPAR-γ Pathway (2020 · Drug Design Development and Therapy · 被引 68)
• Leptin induces NAFLD progression through infiltrated CD8+ T lymphocytes mediating pyroptotic-like cell death of hepatocytes and macrophages (2020 · Digestive and Liver Disease · 被引 36)
• Decreased expression of ATF3, orchestrated by β-catenin/TCF3, miR-17-5p and HOXA11-AS, promoted gastric cancer progression via increased β-catenin and CEMIP (2021 · Experimental & Molecular Medicine · 被引 35)